作者：黄莺俗话说人红是非多。在新冠疫情期间，凭借mRNA疫苗大获成功的Moderna公司，从年营收只有几千万美元的公司，一举跨入年营收200亿美元的公司行列。而这为其也带来了越来越多的专利纠纷。2021年，Moderna与美国国立卫生研究院的mRNA ...

GlaxoSmithKline is suing Moderna for allegedly using technology patented by GSK in its COVID-19 vaccine. Why it matters: It's ...

British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of ...

The lawsuits claim that Moderna used and profited from crucial mRNA technology in its COVID-19 vaccine Spikevax and ...

The Mandl team was originally employed by Novartis, but GSK acquired rights to their work and intellectual property when it ...

GSK filed two lawsuits at the US District of Delaware on 15 October saying that Moderna’s mRNA vaccine product Spikevax ...

The pharma’s lawsuit focuses on scientific work that helped clear the path for creating mRNA vaccines to fight the COVID-19 ...

UK pharma major GSK has sued USA-based Moderna this week, accusing the latter of violating patents protecting GSK’s COVID-19 ...

Recent health news highlights various topics including Abbott's profit rise due to medical device sales, Trump's IVF comments ...

A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

英国制药公司葛兰素史克（GlaxoSmithKline）在特拉华州的一家联邦法院对美国Moderna公司提起诉讼。GSK声称Moderna在开发和销售其COVID-19疫苗Spikevax的过程中侵犯了GSK与信使RNA（mRNA）技术相关的专利。 该诉讼声称，Moderna用于将mRNA传递到细胞中的脂质纳米粒子侵犯了GSK的专利。根据GSK的说法，这些专利是Moderna疫苗产品所使用的mRN ...